Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy

被引:4
|
作者
Wang, Shuo [1 ]
Zheng, Dandan [1 ]
Lin, Chi [1 ]
Lei, Yu [1 ]
Verma, Vivek [2 ]
Smith, April [1 ]
Ma, Rongtao [3 ]
Enke, Charles A. [1 ]
Zhou, Sumin [1 ]
机构
[1] Univ Nebraska, Dept Radiat Oncol, Med Ctr, Omaha, NE 68198 USA
[2] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
stereotactic body radiotherapy; pancreatic cancer; automated treatment planning; dose escalation; personalized treatment; RADIATION-THERAPY SMART; ADAPTIVE RADIOTHERAPY; DE-ESCALATION; PHASE-II; CANCER; IMRT; RADIOSURGERY; GEMCITABINE; HEAD; ADENOCARCINOMA;
D O I
10.1177/1533033819851520
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Stereotactic body radiotherapy has been suggested to provide high rates of local control for locally advanced pancreatic cancer. However, the close proximity of highly radiosensitive normal tissues usually causes the labor-intensive planning process and may impede further escalation of the prescription dose. Purpose: The present study aims to evaluate the consistency and efficiency of Pinnacle Auto-Planning for pancreas stereotactic body radiotherapy with original prescription and escalated prescription. Methods: Twenty-four patients with pancreatic cancer treated with stereotactic body radiotherapy were studied retrospectively. The prescription is 40 Gy over 5 consecutive fractions. Most of patients (n = 21) also had 3 other different dose-level targets (6 Gy/fraction, 5 Gy/fraction, and 4 Gy/fraction). Two types of plans were generated by Pinnacle Auto-Planning with the original prescription (8 Gy/fraction, 6 Gy/fraction, 5 Gy/fraction, and 4 Gy/fraction) and escalated prescription (9 Gy/fraction, 7 Gy/fraction, 6 Gy/fraction, and 5 Gy/fraction), respectively. The same Auto-Planning template, including beam geometry, intensity-modulated radiotherapy objectives and intensity-modulated radiotherapy optimization parameters, were utilized for all the auto-plans in each prescription group. The intensity-modulated radiotherapy objectives do not include any manually created structures. Dosimetric parameters including percentage volume of PTV receiving 100% of the prescription dose, percentage volume of PTV receiving 93% of the prescription dose, and consistency of the dose-volume histograms of the target volumes were assessed. D-max and D-1 cc of highly radiosensitive organs were also evaluated. Results: For all the pancreas stereotactic body radiotherapy plans with the original or escalated prescriptions, auto-plans met institutional dose constraints for critical organs, such as the duodenum, small intestine, and stomach. Furthermore, auto-plans resulted in acceptable planning target volume coverage for all targets with different prescription levels. All the plans were generated in a one-attempt manner, and very little human intervention is necessary to achieve such plan quality. Conclusions: Pinnacle(3) Auto-Planning consistently and efficiently generate acceptable treatment plans for multitarget pancreas stereotactic body radiotherapy with or without dose escalation and may play a more important role in treatment planning in the future.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [31] A memetic algorithm for body gamma knife stereotactic radiotherapy treatment planning
    Liang, Bin
    Liu, Bo
    Zhou, Fugen
    Guo, Bin
    Xu, Xuanang
    Kang, Jingbo
    Li, Jianguo
    Liu, Wei
    WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, 2015, VOLS 1 AND 2, 2015, 51 : 436 - 439
  • [32] Phase I dose-escalation study of helical intensity-modulated radiotherapy-based stereotactic body radiotherapy for hepatocellular carcinoma
    Kim, Jun Won
    Seong, Jinsil
    Lee, Ik Jae
    Woo, Joong Yeol
    Han, Kwang-Hyub
    ONCOTARGET, 2016, 7 (26) : 40756 - 40766
  • [33] The dosimetric impact of implants on the spinal cord dose during stereotactic body radiotherapy
    Yazici, Gozde
    Sari, Sezin Yuce
    Yedekci, Fazli Yagiz
    Yucekul, Altug
    Birgi, Sumerya Duru
    Demirkiran, Gokhan
    Gultekin, Melis
    Hurmuz, Pervin
    Yazici, Muharrem
    Ozyigit, Gokhan
    Cengiz, Mustafa
    RADIATION ONCOLOGY, 2016, 11
  • [34] Biologically effective dose and overall survival in stereotactic body radiotherapy for lung tumors
    Tanaka, Osamu
    Funaguchi, Orihiko
    Toyoshi, Sayaka
    Taniguchi, Takuya
    Ono, Kousei
    Makita, Chiyoko
    Matsuo, Masayuki
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2020, 13 (03) : 353 - 356
  • [35] The Importance of Radiation Planning Guidelines in Spinal Stereotactic Body Radiotherapy
    Haisraely, Ory
    Jaffe, Marcia L.
    Lawrence, Yaacov
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 646 - 652
  • [36] Fractionated Stereotactic Radiotherapy using CyberKnife for the Treatment of Large Brain Metastases: A Dose Escalation Study
    Murai, T.
    Ogino, H.
    Manabe, Y.
    Iwabuchi, M.
    Okumura, T.
    Matsushita, Y.
    Tsuji, Y.
    Suzuki, H.
    Shibamoto, Y.
    CLINICAL ONCOLOGY, 2014, 26 (03) : 151 - 158
  • [37] A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
    Kainuma, Takuro
    Kawakami, Shogo
    Tsumura, Hideyasu
    Satoh, Takefumi
    Tabata, Ken-ichi
    Iwamura, Masatsugu
    Hayakawa, Kazushige
    Ishiyama, Hiromichi
    RADIATION ONCOLOGY, 2019, 14 (01)
  • [38] Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy
    Grimm, Jimm
    LaCouture, Tamara
    Croce, Raymond
    Yeo, Inhwan
    Zhu, Yunping
    Xue, Jinyu
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2011, 12 (02): : 267 - 292
  • [39] A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
    Takuro Kainuma
    Shogo Kawakami
    Hideyasu Tsumura
    Takefumi Satoh
    Ken-ichi Tabata
    Masatsugu Iwamura
    Kazushige Hayakawa
    Hiromichi Ishiyama
    Radiation Oncology, 14
  • [40] Multiagent Chemotherapy Followed by Stereotactic Body Radiotherapy Versus Conventional Radiotherapy for Resected Pancreas Cancer
    Mokhtech, Meriem
    Miccio, Joseph A.
    Johung, Kimberly
    Cecchini, Michael
    Stein, Stacey
    Narang, Amol K.
    Herman, Joseph M.
    Kunstman, John
    Haddock, Michael G.
    Anker, Christopher J.
    Jabbour, Salma
    Hallemeier, Christopher L.
    Jethwa, Krishan R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2022, 45 (11): : 450 - 457